{"name":"Ergotamine","slug":"ergotamine","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Ergotamin","Ergonsvine","Ergotamina","ergotaminum","12'-Hydroxy-2'-methyl-5'α-(phenylmethyl)ergotaman-3',6',18-trione","(5'α)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione","Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'-α)-","Ergo Kranit","Mono, Ergodryl","N02ca02"],"brands":[],"scraped":true,"has_structure":true,"cid":8223,"classes":[],"families":[{"name":"lysergamide","href":"/substituted/lysergamide"}],"physical":[{"label":"Molecular mass","value":"581.70 g/mol","copyable":false},{"label":"Appearance","value":"Needles from alcohol; prisms from benzene; plates from acetone","copyable":false},{"label":"Melting point","value":"213.5 dec °C","copyable":false},{"label":"Decomposition","value":"Decomposition at 212-214 °C.","copyable":false},{"label":"Solubility","value":"Slight","copyable":false},{"label":"Predicted LogP","value":"2","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>33</sub>H<sub>35</sub>N<sub>5</sub>O<sub>5</sub>","copyable":true},{"label":"IUPAC name","value":"(6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","copyable":true},{"label":"SMILES","value":"C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C","copyable":true},{"label":"InChI","value":"InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1","copyable":true},{"label":"InChIKey","value":"XCGSFFUVFURLIX-VFGNJEKYSA-N","copyable":true},{"label":"CAS number","value":"113-15-5","copyable":true},{"label":"UNII","value":"PR834Q503T","copyable":true},{"label":"PubChem CID","value":"8223","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"2 hours","copyable":false},{"label":"Metabolism","value":"Liver","copyable":false},{"label":"Excretion","value":"90% Bile duct","copyable":false},{"label":"Routes of administration","value":"Oral","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Cat",[{"kind":"LD50","organism":"Cat","route":"sc","dose":"11 mg/kg"}]],["Mouse",[{"kind":"LD50","organism":"Mouse","route":"iv","dose":"62 mg/kg"}]],["Rabbit",[{"kind":"LD50","organism":"Rabbit","route":"iv","dose":"100 mg/kg"},{"kind":"LD50","organism":"Rabbit","route":"iv","dose":"3 mg/kg"}]],["Rat",[{"kind":"LD50","organism":"Rat","route":"iv","dose":"80 mg/kg"},{"kind":"LD50","organism":"Rat","route":"Intravenous","dose":"62 mg/kg"}]]]}],"dosing":null,"salts":[{"title":"Ergotamine hemitartrate","name":"hemitartrate","slug":"ergotamine_hemitartrate","drawn":true}],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":1},"reagents":[],"atc":[{"code":"N","description":"Nervous system"},{"code":"N02","description":"Analgesics"},{"code":"N02C","description":"Antimigraine preparations"},{"code":"N02CA","description":"Ergot alkaloids"},{"code":"N02CA02","description":"Ergotamine"}],"mesh":[{"name":"Oxytocics","id":"M0015702"},{"name":"Vasoconstrictor Agents","id":"M0022551"},{"name":"Serotonin Receptor Agonists","id":"M0026371"},{"name":"Analgesics, Non-Narcotic","id":"M0028038"},{"name":"Adrenergic alpha-1 Receptor Agonists","id":"M0543920"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"CYP3A4","mechanisms":["metabolism","induction","inhibition"],"partners":147,"contraindicated":7},{"target":"ADRA1A","mechanisms":["shared target"],"partners":18,"contraindicated":2},{"target":"ADRA1B","mechanisms":["shared target"],"partners":18,"contraindicated":2},{"target":"ADRA1D","mechanisms":["shared target"],"partners":18,"contraindicated":2},{"target":"HTR1B","mechanisms":["shared target"],"partners":14,"contraindicated":12},{"target":"HTR1D","mechanisms":["shared target"],"partners":14,"contraindicated":12},{"target":"HTR1A","mechanisms":["shared target"],"partners":10,"contraindicated":0}],"mechanism":"Ergotamine acts on migraine by one of two proposed mechanisms: 1) activation of 5-HT<sub>1D</sub> receptors located on intracranial blood vessels, including those on arterio-venous anastomoses, leads to vasoconstriction, which correlates with the relief of migraine headache, and 2) activation of 5-HT<sub>1D</sub> receptors on sensory nerve endings of the trigeminal system results in the inhibition of pro-inflammatory neuropeptide release.","side_effects":{"drug_id":3251,"drug_name":"ergotamine","url":"https://sideeffects.embl.de/drugs/3251/pt","atc_codes":["N02CA02"],"side_effects":[{"name":"Asthenia","cui":"C0004093"},{"name":"Cyanosis","cui":"C0010520"},{"name":"Localised oedema","cui":"C0013609"},{"name":"Gangrene","cui":"C0017086"},{"name":"Hypertension","cui":"C0020538"},{"name":"Ischaemia","cui":"C0022116"},{"name":"Nausea","cui":"C0027497"},{"name":"Hypoaesthesia","cui":"C0020580"},{"name":"Sensory loss","cui":"C0278134"},{"name":"Pain","cui":"C0030193"},{"name":"Paraesthesia","cui":"C0030554"},{"name":"Paresthesia of limbs","cui":"C0239385"},{"name":"Pruritus","cui":"C0033774"},{"name":"Tachycardia","cui":"C0039231"},{"name":"Vertigo","cui":"C0042571"},{"name":"Vomiting","cui":"C0042963"},{"name":"Emotional distress","cui":"C0700361"},{"name":"Myalgia","cui":"C0231528"},{"name":"Musculoskeletal discomfort","cui":"C0948594"},{"name":"Pulse absent","cui":"C0277899"},{"name":"Peripheral coldness","cui":"C0277925"},{"name":"Bradycardia","cui":"C0428977"}],"indications":[{"name":"Headache","cui":"C0018681"},{"name":"Migraine","cui":"C0149931"},{"name":"Variants of migraine","cui":"C0042331"},{"name":"Vascular headache","cui":"C0042376"}]},"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[]},{"jurisdiction":"Brazil","status":"D1","act":null,"refs":[3]},{"jurisdiction":"Canada","status":"Schedule VI","act":null,"refs":[]},{"jurisdiction":"United Kingdom","status":"Prescription only","act":null,"refs":[]},{"jurisdiction":"United States","status":"Prescription only","act":null,"refs":[4,5]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Ergotamine"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/8223"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q419186"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00696"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL442"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A64318"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=113-15-5"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0014834"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07544"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID9043774"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Ergotamine"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/PR834Q503T"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/3251/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 8223, Ergotamine. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/8223>https://pubchem.ncbi.nlm.nih.gov/compound/8223</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ergotamine. UNII: PR834Q503T. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/PR834Q503T>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/PR834Q503T</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>","Ergomar- ergotamine tartrate tablet, orally disintegrating. DailyMed. 8 September 2012. <a href='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1bfd4827-5123-4dbb-8f94-7b097f5bfd5c'>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1bfd4827-5123-4dbb-8f94-7b097f5bfd5c</a>","Ergomar sublingual- ergotamine tartrate tablet. DailyMed. 25 October 2022. <a href='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dac9637f-3326-4f25-b7b9-f9f54b738232'>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dac9637f-3326-4f25-b7b9-f9f54b738232</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 03:05:31","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 03:05:27","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 03:05:27","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 03:05:28","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 03:05:27","note":"hmdb.ca refused automated access to HMDB0014834"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 03:05:29","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 03:05:26","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 03:05:27","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 03:05:27","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 03:05:27","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 03:05:27","note":null}],"description":"Ergotamine is a  substance."}